Cargando…

Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma

Antibodies targeting the programmed cell death protein-1 (PD-1) molecule have been reported to hold promising antitumor activities in patients with nasopharyngeal carcinoma (NPC). However, only a small subset of NPC patients benefits from the anti-PD-1 monotherapy and factors that affect the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Liqin, Ma, Yuxiang, Fang, Chao, Peng, Zhuobing, Gao, Fangfang, Moll, Janne Marie, Qin, Shishang, Yu, Qichao, Hou, Yong, Kristiansen, Karsten, Fang, Wenfeng, Brix, Susanne, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428750/ https://www.ncbi.nlm.nih.gov/pubmed/36059644 http://dx.doi.org/10.3389/fonc.2022.953884

Ejemplares similares

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients
por: Fang, Chao, et al.
Publicado: (2022)

Small Intestinal Tuft Cell Activity Associates With Energy Metabolism in Diet-Induced Obesity
por: Arora, Pankaj, et al.
Publicado: (2021)

Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma
por: Ali, Wael A. S., et al.
Publicado: (2023)

Predictive Potentials of ZEB1-AS1 in Colorectal Cancer Prognosis and Their Correlation with Immunotherapy
por: Ruan, Liqin, et al.
Publicado: (2022)

Systems-wide effects of short-term feed deprivation in obese mice
por: Andersen, Daniel, et al.
Publicado: (2021)

Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma
por: Tang, Yanyan, et al.
Publicado: (2017)

A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy
por: Bian, Jin, et al.
Publicado: (2022)

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
por: Fang, Wenfeng, et al.
Publicado: (2014)

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
por: Zhou, Yajuan, et al.
Publicado: (2017)

Retracted: A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Influence of Pre-treatment Saliva Microbial Diversity and Composition on Nasopharyngeal Carcinoma Prognosis
por: Du, Yun, et al.
Publicado: (2022)

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2020)

Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacy
por: Li, Anlin, et al.
Publicado: (2023)

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
por: Huang, Fu-xue, et al.
Publicado: (2022)

Expression of cancer cell-intrinsic PD-1 associates with PD-L1 and p-S6 and predicts a good prognosis in nasopharyngeal carcinoma
por: Zhang, Yuting, et al.
Publicado: (2021)

Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
por: Yao, Han, et al.
Publicado: (2018)

URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)

Outcomes and Experiences of Child-Bearing Women with Nasopharyngeal Carcinoma
por: Ma, Liqin, et al.
Publicado: (2020)

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
por: Babačić, Haris, et al.
Publicado: (2020)

Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma
por: Zhu, Xiaopeng, et al.
Publicado: (2021)

Determinants of survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 therapy
por: Ali, Wael Abdullah Sultan, et al.
Publicado: (2021)

Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period
por: Huang, Huageng, et al.
Publicado: (2023)

Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma
por: Cui, Linchong, et al.
Publicado: (2023)

Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma
por: Hua, Xin, et al.
Publicado: (2020)

Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Lyu, Yingchen, et al.
Publicado: (2020)

Current status and advances of immunotherapy in nasopharyngeal carcinoma
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis
por: Wang, Hai-Yun, et al.
Publicado: (2012)

Assessment of fecal DNA extraction protocols for metagenomic studies
por: Yang, Fangming, et al.
Publicado: (2020)

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2010)

PD-L1 degradation pathway and immunotherapy for cancer
por: Gou, Qian, et al.
Publicado: (2020)

Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma
por: Ma, Yuxiang, et al.
Publicado: (2021)

A Phase I/II Open‐Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors
por: Ma, Yuxiang, et al.
Publicado: (2019)

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses
por: Chen, Yu-Pei, et al.
Publicado: (2021)

Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma
por: Liu, Zijian, et al.
Publicado: (2022)

Season of Birth Impacts the Neonatal Nasopharyngeal Microbiota
por: Schoos, Ann-Marie Malby, et al.
Publicado: (2020)

Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
por: Zhu, Yankun, et al.
Publicado: (2023)

Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
por: Li, Jiang, et al.
Publicado: (2007)

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis
por: Zhang, Yan, et al.
Publicado: (2010)

A d-peptide-based oral nanotherapeutic modulates the PD-1/PD-L1 interaction for tumor immunotherapy
por: Liu, Dan, et al.
Publicado: (2023)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_47pbh65k6qjvdnarvoqsitncug